Arimidex 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FHR0G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,027
Award facts
- Contract value 100% obligated
- $44,026.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,026.89 firm fixed-price delivery order to Amerisourcebergen Drug Corp (Cencora, Inc.) on January 7, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30 units. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of January 8, 2026, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen, operating as a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates capability in delivering diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. As a competitively selected vendor with DLA, Amerisourcebergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles designed to meet global pharmaceutical supply requirements for federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FHR0G?
SPE2DR26FHR0G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FHR0G worth?
The government has obligated $44,027 on SPE2DR26FHR0G.
Is contract SPE2DR26FHR0G an order under another contract?
Yes. SPE2DR26FHR0G is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHR0G competed?
The extent of competition for SPE2DR26FHR0G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award